Favorable cytogenetic abnormalities in secondary leukemia
- 15 June 1989
- Vol. 63 (12) , 2505-2508
- https://doi.org/10.1002/1097-0142(19890615)63:12<2505::aid-cncr2820631224>3.0.co;2-z
Abstract
The authors report on five patients with secondary leukemia (SL) and one of the “specific” chromosomal rearrangements usually encountered in de novo acute nonlymphoblastic leukemia: inv(16), t(15;17), t(8;21), and t(9;11). They were characterized by solid tumor as the primary malignancy in four of five cases, absence of preleukemic phase in all cases, and myelodysplastic features in one of five cases only. All patients achieved complete remission (CR) with aggressive chemotherapy. Only two relapsed, but follow-up is still limited in the three remaining cases. Cytogenetic analysis is important in all younger patients with SL, especially if unusual features (such as absence of preleukemic phase or myelodysplastic features) are found. Aggressive chemotherapy appears to be indicated in those patients if a “specific” rearrangement is found.This publication has 17 references indexed in Scilit:
- Cytogenetic studies on 519 consecutive de novo acute nonlymphocytic leukemiasCancer Genetics and Cytogenetics, 1987
- Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features.Journal of Clinical Oncology, 1986
- Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosisBlood, 1986
- Translocation (9;11)(p21;q23) in a child with acute monoblastic leukemia following 2 1/2 years after successful chemotherapy for neuroblastoma.Journal of Clinical Oncology, 1986
- The association of specific “favorable” cytogenetic abnormalities with secondary leukemiaCancer, 1986
- Secondary chromosome aberrations in the acute leukemiasCancer Genetics and Cytogenetics, 1986
- Chromosome abnormalities in secondary myelodysplastic syndromesScandinavian Journal of Haematology, 1986
- Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patientsCancer, 1984
- Therapy of Secondary Acute Nonlymphocytic Leukemia with CytarabineNew England Journal of Medicine, 1983
- ISCN 1978Cytogenetic and Genome Research, 1978